Zdrowie i gospodarka · 11/06/2007
FDA Proposes Removal of Essential-Use Designations for Certain Ozone-Depleting Substances in Inhalers
The FDA, in consultation with the EPA, is proposing to remove essential-use designations for certain inhalers containing ozone-depleting substances, as therapeutic alternatives without ODS are already available, providing the same public health benefits.